TC BioPharm

TC BioPharm

TC BioPharm is a biotechnology company developing cell therapies for treating cancer and severe viral infections.

All edits

Edits on 23 Feb, 2021
Golden AI"Setting founded date to the company's date of incorporation."
Golden AI edited on 23 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founded date
2013
Edits on 13 Oct, 2020
Daniel Frumkin"added article"
Daniel Frumkin edited on 13 Oct, 2020
Edits made to:
Article (+1003 characters)
Article

In addition to treating cancer the company looks to treat a range of disorders that are brought on by viral infections. They have developed the product ImmuniCell, which is being tested in clinical studies to fight against renal cell carcinoma, non-small cell lung cancer and melanoma patients.

In the long run the company is interested in developing and commercializing their cell-based products and solutions in order to treat diseases across a broad range of patients. They have developed allogenic CAR-T cell therapy products for the purpose of treating cancer, and are developing gamma delta T-cell therapies to fight against infectious diseases.

Gamma Delta T-cells (DGT cells) are a component of white blood cells and are responsible for innate immune system responses. They monitor the body's signs of biological stress and are among the first response options the body has. TC BioPharm looks to utilize the traits of a DGT cell to provide therapeutics that treat diseases and specifically cancer.

Edits on 24 Sep, 2019
Golden AI"Set entity company status to Active"
Golden AI edited on 24 Sep, 2019
Edits made to:
Infobox (--1 properties)
Infobox
Company status
Active
Edits on 26 Mar, 2019
Dawson Sewell
Dawson Sewell edited on 26 Mar, 2019
Edits made to:
Infobox (+14 properties)
Description (+114 characters)
Article (+247 characters)
Further reading (+4 rows) (+16 cells) (+955 characters)
Documentaries, videos and podcasts (+3 rows) (+9 cells) (+297 characters)
Categories (+2 topics)
Related Topics (+3 topics)
Topic thumbnail

TC BioPharm

TC BioPharm is a biotechnology company developing cell therapies for treating cancer and severe viral infections.

Article

TC BioPharm is a biotechnology company developing cell therapies for treating cancer and severe viral infections that is headquartered in Glasgow, Scotland and was founded in 2013 by Angela Scott, Artin Moussavi, David Gallagher, and Michael Leek.

Further reading

Title
Author
Link
Type

Biotech firm confirms cancer therapy deal

BBC News

Web

bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy

Business Wire

Web

Immunotherapy Company TC BioPharm Partners with Trinity College Dublin to Develop V Delta 1 γδ T Cell-based Cancer Treatments

TC BioPharm

Web

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products - World Stem Cell Summit

Katie Odgaard

Web

Documentaries, videos and podcasts

Title
Date
Link

TC BioPharm

October 16, 2014

TC BioPharm - Company Presentation

October 22, 2014

The Big Interview: Angela Scott, co-founder of biotech firm TC BioPharm

February 25, 2018

Infobox
Is a
Company
Industry
Biotechnology
Location
Glasgow
Date incorporated
2013
Categories
Related Topics
Dawson Sewell"Initial topic creation"
Dawson Sewell created this topic on 26 Mar, 2019
Edits made to:
Topic thumbnail

 TC BioPharm

TC BioPharm is a biotechnology company developing cell therapies for treating cancer and severe viral infections.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.